Prevalence and Incidence of Drug-Resistant Temporal Lobe Epilepsy in Qatar.

Boulenouar MesraouaDirk DeleuHassan J Al HailGayane MelikyanMusab Abdalhalim AliNaim HaddadYasir Osman Mohamed AliLubna ElsheikhAli AyyadJon PerkinsGonzalo Alarcon PalomoAli A Asadi-Pooya

Published in: Journal of central nervous system disease (2020)

Our study suggests that 804 to 1609 current patients (with 62-116 additional patients per year) in Qatar are suffering from drug-resistant TLE-HS; emphasis should be placed on the surgical aspect of the current Qatar Comprehensive Epilepsy Program.

Keyphrases

drug resistant
multidrug resistant
acinetobacter baumannii
temporal lobe epilepsy
end stage renal disease
risk factors
newly diagnosed
chronic kidney disease
prognostic factors
quality improvement
patient reported outcomes
cystic fibrosis
patient reported